Rua Bioscience Limited (NZE:RUA)
New Zealand
· Delayed Price · Currency is NZD 0.0300
0.00 (0.00%)
May 14, 2025, 2:51 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 6.71 million as of May 13, 2025. Its market cap has decreased by -39.39% in one year.
Market Cap
6.71M
Enterprise Value
6.68M
Revenue
1.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 6.71M, a decrease of -92.95%. That is a compound annual growth rate of -44.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 6.71M | 9.73% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | 84.16M | -11.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 21.22B |
| EBOS Group | 7.84B |
| Summerset Group Holdings | 2.76B |
| Ryman Healthcare | 2.49B |
| Oceania Healthcare | 477.94M |
| AFT Pharmaceuticals | 273.70M |
| Green Cross Health | 107.70M |
| Radius Residential Care | 78.30M |